C12N 2830/55
From bacteria
Official title: from bacteria
C12N2830/55 (From bacteria) appears on 153 US grants and 124 published applications in this corpus.
Search patents in C12N- Granted patents
- 153
- Published applications
- 124
- Assignees
- 85
- Inventors
- 267
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 21 | 0 |
| 1998 | 13 | 0 |
| 1999 | 7 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 1 |
| 2002 | 5 | 4 |
| 2003 | 4 | 13 |
| 2004 | 2 | 12 |
| 2005 | 1 | 6 |
| 2006 | 4 | 8 |
| 2007 | 5 | 0 |
| 2008 | 3 | 3 |
| 2009 | 3 | 3 |
| 2010 | 4 | 5 |
| 2011 | 5 | 6 |
| 2012 | 5 | 13 |
| 2013 | 6 | 4 |
| 2014 | 5 | 6 |
| 2015 | 3 | 6 |
| 2016 | 2 | 1 |
| 2017 | 3 | 9 |
| 2018 | 5 | 2 |
| 2019 | 0 | 1 |
| 2020 | 2 | 8 |
| 2021 | 3 | 2 |
| 2022 | 0 | 2 |
| 2023 | 2 | 0 |
| 2024 | 3 | 3 |
| 2025 | 0 | 4 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Promoter and use thereof10 Mar 2026US 12,570,989 B2Azenta US, Inc.
- Biosensors for detecting and/or neutralizing bioavailable uranium and related U-sensitive genetic molecular components, gene cassettes, vectors, genetic circuits, compositions, methods and systems10 Mar 2026US 12,571,058 B2Lawrence Livermore National Security, LLC
- Methods and compositions to prevent microbial infection10 Dec 2024US 12,163,135 B2BioPlx, Inc.
- Promoter for heterologous expression20 Aug 2024US 12,065,652 B2BASF SE
- Biosensors for detecting and/or neutralizing bioavailable uranium and related U-sensitive genetic molecular components, gene cassettes, vectors, genetic circuits, compositions, methods and systems13 Feb 2024US 11,898,211 B2Lawrence Livermore National Security, LLC
- Host cell for improving stability of plasmid10 Sep 2026US 2026/0265764 A1Nanjing GenScript Biotech Co., Ltd.
- Binary Self-Amplifying Nucleic Acid Platform and Uses Thereof4 Jun 2026US 2026/0152760 A1
- Means for generating adenoviral vectors for cloning large nucleic acids25 Dec 2025US 2025/0388912 A1Revvity Gene Delivery GmbH
- Methods and compositions to prevent microbial infection13 Nov 2025US 2025/0346910 A1Commense Bio, Inc.
- Expression and secretion system30 Oct 2025US 2025/0333723 A1Genentech, Inc.
Most cited
By later US patents
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Preparation of functional human factor VIII in mammalian cells using methotrexate based selection276US 4,965,199 AGenentech, Inc. · 1990
- Protein production and protein delivery172US 5,641,670 ATranskaryotic Therapies, Inc. · 1997
- Plant promoter .alpha.-glucuronidase gene construct146US 5,268,463 A1993
- Method for introducing and expressing RNA in animal cells143US 6,500,419 B1University of Maryland Biotechnology Institute · 2002